brexucabtagene autoleucel
gilead sciences
['zuma-3', 'car-t', 'tecartus', 'cart,(-cartitude)', 'leusm']
#asco22 #leusm li: low cytokine secretion appears to be correlated w decreased toxicity, but the car-t still show good in vivo expansion. pts w high disease burden still showed good response (durability will be important!; see long term outcomes with tecartus from zuma-3). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)